843 related articles for article (PubMed ID: 10379464)
1. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.
Russell RI
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S14-8. PubMed ID: 10379464
[TBL] [Abstract][Full Text] [Related]
2. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
Chan FK; Graham DY
Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
Russell RI
Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):465-9. PubMed ID: 9494858
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding.
Lanas A
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S37-42. PubMed ID: 10379468
[TBL] [Abstract][Full Text] [Related]
5. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
Yeomans ND
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced gastropathy in elderly Taiwanese.
Wu KL; Liou SH; Lay CS
Hepatogastroenterology; 2000; 47(32):596-600. PubMed ID: 10791246
[TBL] [Abstract][Full Text] [Related]
7. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
[TBL] [Abstract][Full Text] [Related]
8. Clinical symptoms, endoscopic findings and histologic features of gastroduodenal non-steroidal anti-inflammatory drugs lesions.
Aabakken L
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S19-22. PubMed ID: 10379465
[TBL] [Abstract][Full Text] [Related]
9. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
10. Ulcers, Helicobacter pylori infection, platelets and gastrointestinal complications of non-steroidal anti-inflammatory drugs: what are the connections?
McCarthy DM
Eur J Surg Suppl; 2002; (587):89-99. PubMed ID: 16144207
[TBL] [Abstract][Full Text] [Related]
11. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
Koch M
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
[TBL] [Abstract][Full Text] [Related]
12. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
13. Disadvantageous effects of nonsteroidal anti-inflammatory drugs on the alimentary tract.
Cichoz-Lach H; Celiński K
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):403-8. PubMed ID: 12898870
[TBL] [Abstract][Full Text] [Related]
14. Variations in the risk of gastrointestinal hemorrhage with non-steroidal anti-inflammatory drugs and localization of lesions.
Pulanić R; Dubravcić D; Ostojić-Pulanić B; Vrhovac B
Acta Med Croatica; 1998; 52(2):91-8. PubMed ID: 9682495
[TBL] [Abstract][Full Text] [Related]
15. [Development and relapse of gastroduodenal ulcer in patients taking nonsteroid anti-inflammatory drugs: effects of standard risk factors].
Karateev AE; Nasonova VA
Ter Arkh; 2008; 80(5):62-6. PubMed ID: 18590118
[TBL] [Abstract][Full Text] [Related]
16. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
McCarthy DM
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
[TBL] [Abstract][Full Text] [Related]
17. Which patients taking non-aspirin non-steroidal anti-inflammatory drugs bleed? A case-control study.
Hochain P; Berkelmans I; Czernichow P; Duhamel C; Tranvouez JL; Lerebours E; Colin R
Eur J Gastroenterol Hepatol; 1995 May; 7(5):419-26. PubMed ID: 7614104
[TBL] [Abstract][Full Text] [Related]
18. Pharmacoeconomic aspects of non-steroidal anti-inflammatory drug gastropathy.
Walan A; Wahlqvist P
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S79-88. PubMed ID: 10379474
[TBL] [Abstract][Full Text] [Related]
19. Strategies to reduce the GI risks of antiplatelet therapy.
Scheiman JM
Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
[TBL] [Abstract][Full Text] [Related]
20. Effect of gastric mucosal protection in nonrheumatoid patients with short-term nonsteroidal anti-inflammatory drug therapy: a prospective randomized multicenter study.
Miller K
Hepatogastroenterology; 1997; 44(15):872-9. PubMed ID: 9222707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
